A survey of extracorporeal photopheresis treatment in pediatric patients in the United Kingdom

A survey of extracorporeal photopheresis treatment in pediatric patients in the United Kingdom

Abstract Extracorporeal photopheresis (ECP) is a second‐line therapy in acute and chronic GVHD and solid organ transplant rejection. We report ECP use in 98 pediatric patients in seven UK centers from 2010 to 2017, the majority treated for aGVHD (73.5%). ECP was safe and well tolerated including in...

Full description

Bibliographic Details
Main Authors: Aisling M. Flinn, Sheba Macheka, Mary Slatter, Anna‐Maria Ewins, Brenda Gibson, Sarah Lawson, Anna Tailby, Giovanna Lucchini, Helen New, Beki James, Arun Alfred, Julia Scarisbrick, Andrew R Gennery
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:eJHaem
Subjects:
extracorporeal photopheresis
GVHD
immunosuppression
pediatrics
transplantation
Online Access:https://doi.org/10.1002/jha2.58

Internet

https://doi.org/10.1002/jha2.58

Similar Items